IMMU-34. ATRX MUTATIONS PREDICT RESPONSE TO INNATE BASED THERAPY IN GLIOMA

BACKGROUND: Innate based immunotherapies are becoming increasingly important for treating brain tumor patients. Gliomas carry recurrent mutations in regulatory genes that control innate immune signaling responses. About 71% of adult WHO grade II and III gliomas and 57% of secondary glioblastomas als...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Bowie, Michelle, Hariharan, Seethalakshmi, Hostettler, Janell, Roso, Kristen, He, Yiping, Pirozzi, Christopher, Roskoski, Martin, Keir, Stephen, Brown, Michael, Zhang, Gao, Gromeier, Matthias, Yan, Hai, Ashley, David
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847517/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.526
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados